Literature DB >> 2319288

An immunocytochemical comparison of glial fibrillary acidic protein, S-100p and vimentin in human glial tumors.

L Nakopoulou1, E Kerezoudi, T Thomaides, B Litsios.   

Abstract

Immunostaining patterns of glial fibrillary acidic protein (GFAP), S-100 protein (S-100p) and vimentin were studied using immunohistochemical techniques on 48 paraffin embedded glial tumors. GFAP was positive in all tumor cases except in two oligodendrogliomas. S-100p was found in most astroglial tumors and in half of the oligodendrogliomas. Vimentin was positive in many astrocytomas but in no oligodendrogliomas. Most astroglial tumors showed similar immunoreactivity for GFAP and S-100p. Fibrillary processes, however, showed stronger and more crisp staining with anti-GFAP than with anti-S-100p, whereas cell nuclei were labeled only for S-100p. Vimentin was localised mainly in juxtanuclear positions. In many astrocytomas with different degrees of malignancy co-expression of GFAP, S-100p and vimentin was found. The presence of GFAP and S-100p was not correlated with the degree of differentiation in astrocytomas. Vimentin was more positive in anaplastic astrocytomas but this finding was not statistically significant. It seems that GFAP is a superior marker to S-100p and vimentin in the identification of human gliomas.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2319288     DOI: 10.1007/bf00182084

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.130


  28 in total

1.  Different intermediate-sized filaments distinguished by immunofluorescence microscopy.

Authors:  W W Franke; E Schmid; M Osborn; K Weber
Journal:  Proc Natl Acad Sci U S A       Date:  1978-10       Impact factor: 11.205

2.  Contribution of immunohistochemistry to diagnostic problems of human cerebral tumors.

Authors:  L F Eng; L J Rubinstein
Journal:  J Histochem Cytochem       Date:  1978-07       Impact factor: 2.479

Review 3.  Glial fibrillary acidic protein (GFAP): the major protein of glial intermediate filaments in differentiated astrocytes.

Authors:  L F Eng
Journal:  J Neuroimmunol       Date:  1985-06       Impact factor: 3.478

4.  [Studies on the immunohistochemical localization of S-100 and glial fibrillary acidic proteins in the rat nervous system and in human brain tumors (author's transl)].

Authors:  H Yamaguchi
Journal:  No To Shinkei       Date:  1980-10

5.  Immunohistochemical demonstration of vimentin in human cerebral tumors.

Authors:  D Schiffer; M T Giordana; A Mauro; A Migheli; I Germano; G Giaccone
Journal:  Acta Neuropathol       Date:  1986       Impact factor: 17.088

6.  Co-expression of glial fibrillary acidic protein- and vimentin-type intermediate filaments in human astrocytomas.

Authors:  M J Herpers; F C Ramaekers; J Aldeweireldt; O Moesker; J Slooff
Journal:  Acta Neuropathol       Date:  1986       Impact factor: 17.088

7.  Products of cells cultured from gliomas. VI. Immunofluorescent, morphometric, and ultrastructural characterization of two different cell types growing from explants of human gliomas.

Authors:  P E McKeever; B H Smith; J A Taren; R L Wahl; P L Kornblith; B M Chronwall
Journal:  Am J Pathol       Date:  1987-05       Impact factor: 4.307

8.  Vimentin and glial fibrillary acidic protein in human brain tumors.

Authors:  W K Yung; M Luna; A Borit
Journal:  J Neurooncol       Date:  1985       Impact factor: 4.130

9.  Expression of glial and vimentin type intermediate filaments in cultures derived from human glial material.

Authors:  M Osborn; M Ludwig-Festl; K Weber; A Bignami; D Dahl; K Bayreuther
Journal:  Differentiation       Date:  1981       Impact factor: 3.880

10.  Intermediate-sized filaments of human endothelial cells.

Authors:  W W Franke; E Schmid; M Osborn; K Weber
Journal:  J Cell Biol       Date:  1979-06       Impact factor: 10.539

View more
  7 in total

1.  Diagnosis of malignant glioma: role of neuropathology.

Authors:  Daniel J Brat; Richard A Prayson; Timothy C Ryken; Jeffrey J Olson
Journal:  J Neurooncol       Date:  2008-08-20       Impact factor: 4.130

2.  Malignant properties of P635 glioma are independent of glial fibrillary acidic protein expression.

Authors:  A F Chambers; G H Denhardt; S M Wilson; J G Cairncross
Journal:  J Neurooncol       Date:  1991-08       Impact factor: 4.130

Review 3.  Classification of subpopulations of cells within human primary brain tumors by single cell gene expression profiling.

Authors:  Elin Möllerström; Bertil Rydenhag; Daniel Andersson; Isabell Lebkuechner; Till B Puschmann; Meng Chen; Ulrika Wilhelmsson; Anders Ståhlberg; Kristina Malmgren; Milos Pekny
Journal:  Neurochem Res       Date:  2014-09-24       Impact factor: 3.996

4.  Immunohistochemical expression of glial fibrillary acidic protein and CAM5.2 in glial tumors and their role in differentiating glial tumors from metastatic tumors of central nervous system.

Authors:  Rama Goyal; Satyavir Kumar Mathur; Sumiti Gupta; Rahul Goyal; Sanjay Kumar; Ashima Batra; Sonia Hasija; Rajeev Sen
Journal:  J Neurosci Rural Pract       Date:  2015 Oct-Dec

Review 5.  The Role of the S100 Protein Family in Glioma.

Authors:  Haopeng Wang; Xiang Mao; Lei Ye; Hongwei Cheng; Xingliang Dai
Journal:  J Cancer       Date:  2022-08-01       Impact factor: 4.478

6.  Revisiting vimentin: a negative surrogate marker of molecularly defined oligodendroglioma in adult type diffuse glioma.

Authors:  Seong-Ik Kim; Kwanghoon Lee; Jeongmo Bae; Sungyoung Lee; Hongseok Yun; Chul-Kee Park; Seung Hong Choi; Christopher Alec Maquiling; Sung-Hye Park; Jae-Kyung Won
Journal:  Brain Tumor Pathol       Date:  2021-08-02       Impact factor: 3.298

7.  Importance of GFAP isoform-specific analyses in astrocytoma.

Authors:  Emma J van Bodegraven; Jessy V van Asperen; Pierre A J Robe; Elly M Hol
Journal:  Glia       Date:  2019-01-22       Impact factor: 7.452

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.